Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Boeing, General Electric, Moderna, Citigroup, Lockheed Martin, Celestica, and RTX are the seven Defense stocks to watch today, according to MarketBeat’s stock screener tool. Defense stocks are shares ...

AbbVie, Thermo Fisher Scientific, and Moderna are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks represent shares of companies that focus on ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...

U.S. stock futures point lower as investors await tomorrow's announcement on reciprocal tariffs, and OpenAI announces a $40 ...

Organizations that develop sophisticated approaches to IP risk management can protect their exit potential and create ...

The stock market faced a challenging day as risk sentiment remained under pressure on Wall Street. The S&P 500 experienced a ...